We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current USNA market cap is 836.39M. The company's latest EPS is USD 3.3153 and P/E is 13.11.
| Quarter End | Oct 2022 | Dec 2022 | Apr 2023 | Jul 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 233.3M | 227.96M | 248.36M | 238.2M | 213.37M |
| Operating Income | 22.63M | 22.55M | 26.85M | 24.4M | 17.61M |
| Net Income | 14.93M | 12.8M | 18.38M | 17.29M | 11.35M |
| Year End 30 December 2023 | 2019 | 2021 | 2022 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.06B | 1.13B | 1.19B | 998.6M | 921.01M |
| Operating Income | 146.19M | 176.49M | 170.19M | 107.61M | 93.07M |
| Net Income | 100.53M | 124.66M | 116.51M | 69.35M | 63.79M |
| Quarter End | Oct 2022 | Dec 2022 | Apr 2023 | Jul 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 556.06M | 596.55M | 605.53M | 602.68M | 601.15M |
| Total Liabilities | 144.96M | 162.08M | 150.18M | 133.86M | 130.75M |
| Total Equity | 411.1M | 434.47M | 455.35M | 468.82M | 470.39M |
| Year End 30 December 2023 | 2019 | 2021 | 2022 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 516.93M | 640.89M | 577.74M | 596.55M | 632.76M |
| Total Liabilities | 165.22M | 199.24M | 182.62M | 162.08M | 135.56M |
| Total Equity | 351.71M | 441.65M | 395.12M | 434.47M | 497.2M |
| Quarter End | Oct 2022 | Dec 2022 | Apr 2023 | Jul 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 63.44M | 103.9M | 12.83M | 22.38M | 44.62M |
| Investing | -9.09M | -12.37M | -3.38M | -3.2M | -4.65M |
| Financing | -29.94M | -30.09M | -3.2M | -3.25M | -14.9M |
| Year End 30 December 2023 | 2019 | 2021 | 2022 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 126.73M | 160.4M | 121.23M | 103.9M | 70.64M |
| Investing | 47.49M | -33.96M | -14.19M | -12.37M | -11.98M |
| Financing | -152.05M | -59.44M | -181.41M | -30.09M | -14.24M |
| Market Cap | 836.39M |
| Price to Earnings Ratio | 13.11 |
| Price to Sales Ratio | 0.91 |
| Price to Cash Ratio | 2.53 |
| Price to Book Ratio | 1.68 |
| Dividend Yield | - |
| Shares Outstanding | 19.24M |
| Average Volume (1 week) | 82.16k |
| Average Volume (1 Month) | 89.3k |
| 52 Week Change | -33.33% |
| 52 Week High | 69.60 |
| 52 Week Low | 42.70 |
| Spread (Intraday) | 2.27 (5.12%) |
| Company Name | USANA Health Sciences |
| Address |
15 west south temple salt lake city, utah 84101 |
| Website | https://www.usana.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
